Charles Conway

Professor of Psychiatry, Professor of Radiology

    • 1200 Citations
    19982020

    Research output per year

    If you made any changes in Pure these will be visible here soon.

    Personal profile

    Research interests

    My interest is in understanding how mood disorders (depression, bipolar disorder) affect the brain. In particular, my current interest is in severe (treatment-resistant) mood disorders and new treatments for these disorders. I head up the Treatment-resistant Depression and Neurostimulation Clinic and am involved in several studies on advanced treatments of these disorders.

    Areas of Clinical Interest

    Vagus nerve stimulation for treatment resistant depression, bipolar disorder, mood disorders.

    Fingerprint Dive into the research topics where Charles Conway is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    • 6 Similar Profiles

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output

    150 HAM-D6 Outcomes in a Randomized, Controlled Trial Evaluating the Utility of Combinatorial Pharmacogenomics in Depression

    Dunlop, B. W., Parikh, S. V., Patel, M., Rothschild, A. J., Thase, M. E., DeBattista, C., Conway, C. R., Forester, B. P., Shelton, R. C., Macaluso, M., Li, J., Brown, K., Brown, L., Jablonski, M. R. & Greden, J. F., Apr 1 2020, In : CNS Spectrums. 25, 2, p. 295-296 2 p.

    Research output: Contribution to journalArticle

    Open Access
  • A prospective, multi-center randomized, controlled, blinded trial of vagus nerve stimulation for difficult to treat depression: A novel design for a novel treatment

    Conway, C. R., Olin, B., Aaronson, S. T., Sackeim, H. A., Bunker, M., Kriedt, C., Greco, T., Broglio, K., Vestrucci, M. & Rush, A. J., Aug 2020, In : Contemporary Clinical Trials. 95, 106066.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder

    Shelton, R. C., Parikh, S. V., Law, R. A., Rothschild, A. J., Thase, M. E., Dunlop, B. W., DeBattista, C., Conway, C. R., Forester, B. P., Macaluso, M., Hain, D. T., Aguilar, A. L., Brown, K., Lewis, D. J., Jablonski, M. R. & Greden, J. F., Aug 2020, In : Psychiatry Research. 290, 113017.

    Research output: Contribution to journalArticle

    Open Access
  • Combinatorial PharmacogenomicTesting Improves Outcomes for Older Adults With Depression

    Forester, B. P., Parikh, S. V., Weisenbach, S., Ajilore, O., Vahia, I., Rothschild, A. J., Thase, M. E., Dunlop, B. W., DeBattista, C., Conway, C. R., Shelton, R. C., Macaluso, M., Li, J., Traxler, P., Logan, J., Brown, L., Dechairo, B. & Greden, J. F., Jan 1 2020, (Accepted/In press) In : American Journal of Geriatric Psychiatry.

    Research output: Contribution to journalArticle

    Open Access
  • Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents

    Kalmoe, M. C., Janski, A. M., Zorumski, C. F., Nagele, P., Palanca, B. J. & Conway, C. R., May 15 2020, In : Journal of the Neurological Sciences. 412, 116778.

    Research output: Contribution to journalReview article

  • 2 Scopus citations